Tag: healthcare
-
AbbVie looks to new drugs amidst increased competition for Humira
Now that its blockbuster immune-disease therapy Humira is facing lower priced competition, AbbVie is turning to a pair of next-generation successors to replenish the billions of dollars in sales that will be lost, Chief Executive Richard Gonzalez said. It is also betting on four drug approvals by the end of next year. In addition, AbbVie is lifting a self-imposed…
-
Judge rejects J&J attempt to push talc lawsuits to bankruptcy court
Johnson & Johnson (JNJ) plans to challenge the ruling issued today. The Third U.S. Circuit Court of Appeals on Monday dismissed the chapter 11 case of J&J subsidiary LTL Management LLC, which the consumer-health-goods giant created in 2021 to move to bankruptcy court the mass lawsuits alleging its talc-based baby powder products caused cancer. The…
-
Johnson & Johnson cuts production of its COVID-19 vaccine
The New Brunswick, N.J., pharmaceutical company in recent months terminated manufacturing agreements with companies that helped produce the shot during the pandemic such as Catalent Inc. and Sanofi SA. Meanwhile, a partnership with rival Merck & Co. to help make the shots, forged at the urging of the U.S. government, hasn’t lived up to expectations. The companies are now engaged in arbitration. …
-
Omega Healthcare dividend on the bubble?
Tuesday Omega Healthcare Investors (OHI) issued an investor presentation that contained a warning of a decline in cash flow in the first quarter of 2023. The company proposed restructuring two large tenants, LaVie and Mapelwood because they are not covering rent obligations. As a result, Omega will be divesting 11 LaVie properties and placed Maplewood…
-
J&J names executives to helm spin-off consumer health company
J&J said Wednesday it has named Thibaut Mongon as chief executive officer designate of the future consumer-health products company, which J&J plans to split off sometime in 2023. Mr. Mongon, 52, has more than 20 years of experience at J&J and has served as executive vice president and world-wide chairman of the health-products company’s consumer business since 2019. J&J…
-
Everyone wants dividend stocks!
Energy companies aren’t increasing natural gas supplies, J&J files lawsuit, and Economic uncertainty pushing investors to dividend stocks.